Read + Share
Amedeo Smart
Independent Medical Education
Mankerious N, Toelg R, Vogel B, Sartori S, et al. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease. Am J Cardiol 2024;225:25-34.PMID: 38871156
Email
LinkedIn
Privacy Policy